US EditionChronic Kidney Disease Occurs in 30% of Patients with Tests Recorded in the Health System
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
The Spanish Federation of Associations for the Fight Against Kidney Diseases (ALCER) and Novartis have presented the first Atlas of Chronic Glomerulonephritis (CG), one of the leading causes of chronic kidney disease (CKD) in Spain, second only to diabetes mellitus and hypertension. This pioneering study, endorsed by the Spanish Society of Nephrology (S.E.N.), is the first to incorporate the perspectives of patients and caregivers and describes …
In recent years, there is a mineral that has been attracting attention as a cause of chronic kidney disease and shortening kidney lifespan. That mineral is "phosphorus." You may have heard of it, but you probably have no idea what it is contained in or what its function is...
A research programme with real-life data developed in Spain by AstraZeneca has shown that chronic kidney disease is present in 30 percent of patients with analytics registered in primary care centers and the country's reference hospitals included in the BIG-PAC database.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
